Factor VIII inhibitor associated with peginterferon

被引：14

作者：

Herman, C ^{[1
]}

Boggio, L ^{[1
]}

Green, D ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA

来源：

HAEMOPHILIA | 2005年 / 11卷 / 04期

关键词：

factor VIII inhibitor; hepatitis C; interferon;

D O I：

10.1111/j.1365-2516.2005.01089.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present a case of a 53-year-old black male who developed a factor VIII inhibitor during his treatment for hepatitis C virus infection with peginterferon. The development of inhibitors against factor VIII during peginterferon therapy has been rarely reported. We have reviewed the current literature and the following case presentation provides the first demonstration, to our knowledge, in which chronic exposure to peginterferon is associated with an acquired factor VIII inhibitor.

引用

页码：408 / 410

页数：3

共 12 条

[1]

Boggio L N, 2001, Rev Clin Exp Hematol, V5, P389, DOI 10.1046/j.1468-0734.2001.00049.x

[2] CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis [J].